OQRO

Lifemd

LFMD · NASDAQ · Health Care · Services-Offices & Clinics Of Doctors Of Medicine

Services-Offices & Clinics Of Doctors Of Medicine company based in New York, Ny.

Example public filing

SEC Form 4

Chief Marketing Officer sold ~$54K

Jessica Friedeman, Chief Marketing Officer at Lifemd, sold ~$54K of Lifemd shares.

~$54K
Approx. value · 15K sh @ $3.61
205K
Holds after · shares reported
Traded
Dec 9, 2025
Filed
Dec 11, 2025

Data as of Oct 11, 2026. A real record from the official source, chosen as the most recent insider trade or, failing that, the most recent filing of another kind; not a recommendation.

On file for LFMD, last 12 months

14
Insider filings
0
Congress trades
0
Fund positions
0
Federal contracts

Records OQRO holds, counted by their date; a 13F position is counted once per quarter it is reported.

Insider buying and selling since 2017

Insiders of Lifemd reported 145 open-market purchases and 26 sales since 2017; purchases in 8 different years, most recently 2024.

YearBoughtSold
2025—
15×
2024
1×
1×
2023
16×
—
2022
3×
—
2021
33×
—
2020
15×
1×
2019
47×
—
2018
26×
9×
2017
4×
—

Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.

See the full picture with OQRO Pro.

14 records for Lifemd in the last 12 months, each linked to its filing. Full histories, the screener, alerts for the companies you follow and Ask OQRO.

Latest disclosures

SourceWhoAction
Unlock full access — $9.99/month

Secure payment by Stripe. Renews every month until you cancel; cancel anytime from your account. No free trial.

Continue exploring the free preview

Public previews are free. Full research requires Pro. No free trial.

What this page holds

  • Insider trades and planned sales
  • Politician trades (House and Senate)
  • Fund holdings from 13F filings
  • Federal contracts, lobbying and short selling
  • Full history and context, with a link to every filing

What OQRO is

OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.

Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.

Questions about Lifemd insider trading

Have Lifemd insiders bought shares recently?

No open-market purchase by an insider of Lifemd was filed in the last 90 days. The latest on record was on Sep 11, 2024.

How often do Lifemd insiders buy and sell shares?

Since 2017, Lifemd insiders reported 145 open-market purchases and 26 sales on Forms 4 and 5, with purchases in 8 different years, most recently 2024.

Do members of Congress trade LFMD?

No trade in Lifemd (LFMD) was disclosed by a member of Congress in the last 12 months.

When does Lifemd report its next results?

Lifemd's next results are expected on Nov 16, 2026. The date can move until the company confirms it. Insiders often trade in the weeks right after results.

Where does this data come from?

From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.

What this filing is, free to read